The Battle Within: Using the Immune System to Fight Brain Cancer

March 13, 2018 by

Camilo Fadul, MD, and CIC member, Lawrence Lum,Cancer-fighting immunotherapy offers new hope for patients battling glioblastoma, a deadly form of brain cancer. A clinical trial is underway at UVA to test a novel treatment that uses the patient’s own immune system to recognize, target, and kill glioblastoma cells. This approach already has shown promise for other diseases, including breast, prostate, and pancreatic cancers, and non-Hodgkin’s lymphoma.

Led by Camilo Fadul, MD, and CIC member, Lawrence Lum, MD, DSC, Phase 1 of the clinical trial was made possible through seed funding awarded in 2017 by the UVA Brain Institute. UVA is the only institution in the world to test this new strategy to fight glioblastoma.

 

Read more….